JPH1073596A - Method for detecting or measuring immunological active substance - Google Patents

Method for detecting or measuring immunological active substance

Info

Publication number
JPH1073596A
JPH1073596A JP23182696A JP23182696A JPH1073596A JP H1073596 A JPH1073596 A JP H1073596A JP 23182696 A JP23182696 A JP 23182696A JP 23182696 A JP23182696 A JP 23182696A JP H1073596 A JPH1073596 A JP H1073596A
Authority
JP
Japan
Prior art keywords
voltage
detecting
active substance
reagent
immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP23182696A
Other languages
Japanese (ja)
Inventor
Keisuke Iwata
恵助 岩田
Yoshinori Yoshimura
佳典 吉村
Masao Karube
征夫 軽部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A & T Kk
Tokuyama Corp
Original Assignee
A & T Kk
Tokuyama Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & T Kk, Tokuyama Corp filed Critical A & T Kk
Priority to JP23182696A priority Critical patent/JPH1073596A/en
Publication of JPH1073596A publication Critical patent/JPH1073596A/en
Withdrawn legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To accelerate immunological aggregation reaction and to make it possible to perform highly sensitive detection and measurement by applying a minute voltage on a reaction system for detecting immunological active substance. SOLUTION: As immunological active substance, serum protein such as material, e.g. albumin, transferrin or the like, which is measured by immunological aggregation reaction, is used. As the minute voltage, DC, DC pulses or AC is used, and the voltage in the range, wherein the reaction system does not cause electrolysis, is used. As the measuring method, a sample is added into solution, wherein buffer is the main component, e.g. the reagent (antiserum liquid) containing specified specimen is added after the processing at the specified temperature and time. Thereafter the processing is performed at the specified temperature and time. Then, after the specimen is added, the changing amount of turbidity is obtained with the minute voltage being applied.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は特に担体を含まない
試薬を用いる免疫学的凝集反応により、免疫学的反応性
物質を検出又は測定する方法に関する。更に詳しくは、
該反応系に直流、直流パルス、若しくは交流に由来する
微小電圧を印加することにより、免疫学的反応性物質を
迅速且つ簡便に、しかも高感度で検出又は測定する方法
に関する。
The present invention relates to a method for detecting or measuring an immunologically reactive substance by an immunological agglutination reaction using a reagent containing no carrier. More specifically,
The present invention relates to a method for detecting or measuring an immunologically reactive substance quickly and simply and with high sensitivity by applying a small voltage derived from direct current, direct current pulse, or alternating current to the reaction system.

【0002】[0002]

【従来の技術】免疫学的反応性物質は、免疫学的凝集反
応により、不溶性凝集塊を形成するのでこれを検出する
ことにより、免疫学的反応性物質を検出又は測定するこ
とが可能である。免疫学的反応性物質を検出又は測定す
る方法として、免疫比濁法、免疫比朧法、この両者を組
み合わせた積分球濁度法が知られている。抗原となる高
分子タンパク質の分子表面には多くのエピトープがあ
り、これと相補的構造を持つ抗体が接近すると、両者は
疎水結合、水素結合、ファンデルワールス力等によっ
て、不溶性凝集塊を形成し濁度を生ずるので、この濁度
を光学的に測定して定量分析することが可能となるので
ある。これらの方法は、簡便性、迅速性、経済性等の諸
点において臨床検査の方法としては極めて有用である
が、検出できる免疫学的反応性物質の感度に限りがある
ため、更に低濃度域の免疫学的反応性物質を検出するた
めには、ラテックス、リポソーム、金コロイド等の担体
粒子に抗体若しくは抗原を担持した高感度化試薬が用い
られている。これら免疫学的凝集反応は、一般に撹拌翼
等で撹拌されることにより開始され、37℃の温度下で
行われる。このとき測定(反応)に要する時間は約10
分である。
2. Description of the Related Art An immunologically reactive substance forms an insoluble aggregate by an immunological agglutination reaction, and by detecting this, it is possible to detect or measure the immunologically reactive substance. . As a method for detecting or measuring an immunologically reactive substance, an immunoturbidimetric method, an immunoturbidimetric method, and an integrating sphere turbidity method in which both are combined are known. There are many epitopes on the molecular surface of the macromolecule protein that serves as an antigen.When an antibody with a complementary structure approaches the epitope, they form an insoluble aggregate due to hydrophobic bonding, hydrogen bonding, van der Waals force, etc. Since turbidity is generated, the turbidity can be optically measured and quantitatively analyzed. These methods are extremely useful as clinical testing methods in terms of simplicity, speed, economy, etc., but the sensitivity of detectable immunologically reactive substances is limited. In order to detect an immunologically reactive substance, a high sensitivity reagent in which an antibody or an antigen is supported on carrier particles such as latex, liposome, and colloidal gold is used. These immunological agglutination reactions are generally started by stirring with a stirring blade or the like, and are performed at a temperature of 37 ° C. At this time, the time required for measurement (reaction) is about 10
Minutes.

【0003】[0003]

【発明が解決しようとする課題】本発明者らは、免疫比
濁法若しくは免疫比朧法に用いられている担体を含有せ
ず、抗体若しくは抗原を浮遊させた緩衝液からなる試薬
を使用して、従来法よりも免疫学的凝集反応を促進さ
せ、高感度で免疫学的反応性物質を検出又は測定する方
法を知見し、本発明に到達した。
DISCLOSURE OF THE INVENTION The present inventors have used a reagent comprising a buffer in which an antibody or an antigen is suspended without containing a carrier used in an immunoturbidimetry or an immunoturbidimetry. Thus, the present inventors have found a method for promoting an immunological agglutination reaction more than the conventional method and detecting or measuring an immunologically reactive substance with high sensitivity, and have reached the present invention.

【0004】[0004]

【課題を解決するための手段】本発明は、抗原若しくは
抗体を試薬として用いて、免疫学的凝集反応により免疫
学的反応性物質を検出又は測定する方法であって、該反
応系に微小電圧を印加することを特徴とする方法を提供
する。本発明において、免疫学的凝集反応とは、抗原抗
体反応、特異的レセプターとの反応等を利用した方法で
あり、定性法及び定量法の両方を含むものである。本発
明における免疫学的反応性物質は、上記の免疫学的凝集
反応によって、測定され得る物質から選択できる。例え
ばCRP、アルブミン、トランスフェリン、ミオグロビ
ン、LP(a)、C4、C3、IgG、IgM、α1ア
ンチトリプシン等の血清蛋白が挙げられる。また、検出
範囲は概ね10μg/dl〜100mg/dl、検出感
度は約10μg/dl〜1mg/dlである。試薬とし
て用いる抗原若しくは抗体としては、例えば上記血清蛋
白を免疫学的に認識し得る抗体が用いられる。
SUMMARY OF THE INVENTION The present invention relates to a method for detecting or measuring an immunologically reactive substance by immunological agglutination using an antigen or an antibody as a reagent. Is provided. In the present invention, the immunological agglutination reaction is a method utilizing an antigen-antibody reaction, a reaction with a specific receptor, and the like, and includes both a qualitative method and a quantitative method. The immunologically reactive substance in the present invention can be selected from substances that can be measured by the above-mentioned immunological agglutination reaction. Examples include serum proteins such as CRP, albumin, transferrin, myoglobin, LP (a), C4, C3, IgG, IgM, α1 antitrypsin and the like. The detection range is generally 10 μg / dl to 100 mg / dl, and the detection sensitivity is about 10 μg / dl to 1 mg / dl. As the antigen or antibody used as the reagent, for example, an antibody capable of immunologically recognizing the above serum protein is used.

【0005】本発明において、微小電圧は直流、直流パ
ルス、若しくは交流に由来するものである。微小電圧
は、有利には、反応系が電気分解を実質的に起こさない
範囲の電圧、例えば反応系の電気伝導度が17.4mS
/cm(生理食塩水相当)のとき、電界強度2.4V/
mmの直流パルス電圧(パルス幅10μS、10KH
z)である。しかし、前記した電圧は電極の材質、面
積、印加時間等により変動する。本発明における交流電
圧の波形は、連続波、パルス波のいずれであってもよ
く、また任意の形状とし得るが、好ましくは正弦波、方
形波、矩形波である。
In the present invention, the minute voltage is derived from direct current, direct current pulse, or alternating current. The small voltage is preferably a voltage in a range where the reaction system does not substantially cause electrolysis, for example, when the electric conductivity of the reaction system is 17.4 mS.
/ Cm (equivalent to saline), electric field strength 2.4V /
mm DC pulse voltage (pulse width 10 μS, 10 KH
z). However, the aforementioned voltage varies depending on the material, area, application time, and the like of the electrode. The waveform of the AC voltage in the present invention may be any of a continuous wave and a pulse wave, and may have an arbitrary shape, but is preferably a sine wave, a square wave, or a rectangular wave.

【0006】本発明の免疫学的反応性物質の代表的な測
定装置は、例えば図1に示すように、直流パルス電圧、
交流電圧、直流電圧等の任意電圧が印加できる電源装
置、試薬を含む反応系に微小電圧を印加するための容器
内側面に電極を貼り付けた電極付き容器、電圧、周波
数、パルス幅をモニタするためのオシロスコープ、濁度
測定を行う分光光度計等からなる。電源装置としては、
任意のパルス発生装置、例えば市販のファンクションジ
ェネレータや細胞刺激装置等を使用することができる。
電極付き容器としてはガラス、プラスチック等の絶縁性
容器を用いることができ、電極材料としては、白金、ニ
ッケル等を用いることができる。
A typical measuring device for an immunologically reactive substance of the present invention is, for example, as shown in FIG.
A power supply device that can apply an arbitrary voltage such as AC voltage or DC voltage, a container with electrodes attached to the inner surface of the container for applying a small voltage to a reaction system containing a reagent, and monitoring of voltage, frequency, and pulse width And an oscilloscope for measuring the turbidity. As a power supply,
An arbitrary pulse generator, for example, a commercially available function generator or cell stimulator can be used.
As the container with electrodes, an insulating container such as glass or plastic can be used, and as the electrode material, platinum, nickel, or the like can be used.

【0007】免疫学的反応性物質の存在を検出又は測定
する方法としては、検体を緩衝液を主成分とする溶液に
加え、通常、室温〜37℃で、0〜5分間処理した後、
次いで、例えば所定の抗体を含む試薬液(抗血清液)を
加えた後、或いは緩衝液を主成分とする溶液に抗血清液
を加え、通常、室温〜37℃で、0〜5分間処理し、次
いで検体を加えた後、微小電圧を印加しながら若しくは
微小電圧を印加した後、例えば前出の測定装置を用いて
濁度変化量を求める方法が挙げられる。後者の試薬を含
む溶液に検体を加える方法では、微小電圧を印加しなが
ら又は印加直後に検体を加え、次いで濁度変化を測定す
ることもできる。
As a method for detecting or measuring the presence of an immunologically reactive substance, a sample is added to a solution containing a buffer as a main component, and the mixture is usually treated at room temperature to 37 ° C. for 0 to 5 minutes.
Then, for example, after adding a reagent solution (antiserum solution) containing a predetermined antibody or to a solution containing a buffer as a main component, the antiserum solution is usually treated at room temperature to 37 ° C for 0 to 5 minutes. Then, after adding a specimen, while applying a minute voltage or after applying a minute voltage, for example, a method of obtaining the turbidity change amount using the above-described measuring device can be used. In the latter method of adding a specimen to a solution containing a reagent, the specimen can be added while applying a minute voltage or immediately after the application, and then a change in turbidity can be measured.

【0008】本発明に用いられる試薬は、通常、水系媒
体中に分散して用いられる。試薬を含む水系媒体中の塩
濃度は特に規定されないが、好ましくは電気伝導度0〜
100mS/cmとなる濃度であり、より好ましくは2
〜60mS/cmである。塩としては、例えば塩化カリ
ウム、塩化ナトリウム、硝酸ナトリウム、硝酸アンモニ
ウム等が挙げられ、特に塩化カリウム、塩化ナトリウム
が好ましい。試薬を含む水系媒体の組成としては、当業
者にはよく知られている組成が使用できる。試薬には、
例えばアルブミン等のタンパク、ポリエチレングリコー
ル等の高分子、ツイーン、トライトン等の界面活性剤、
アジ化ナトリウム等の防腐剤等が添加されていてもよ
い。反応系の電気伝導度は小さい方が好ましく、電気伝
導度が小さくなると該反応系に印加できる電界強度を大
きくできるので免疫学的凝集反応の促進効果が得られ易
く望ましい。
The reagent used in the present invention is usually used by dispersing it in an aqueous medium. The salt concentration in the aqueous medium containing the reagent is not particularly limited, but is preferably 0 to 0.
The concentration is 100 mS / cm, more preferably 2 mS / cm.
6060 mS / cm. Examples of the salt include potassium chloride, sodium chloride, sodium nitrate, ammonium nitrate and the like, and potassium chloride and sodium chloride are particularly preferable. As the composition of the aqueous medium containing the reagent, a composition well known to those skilled in the art can be used. Reagents include:
For example, proteins such as albumin, polymers such as polyethylene glycol, surfactants such as Tween and Triton,
Preservatives such as sodium azide may be added. It is preferable that the electric conductivity of the reaction system is small. If the electric conductivity is low, the intensity of the electric field that can be applied to the reaction system can be increased, so that the effect of promoting the immunological agglutination reaction can be easily obtained.

【0009】[0009]

【実施例】以下、実施例および比較例をもって本発明を
詳細に説明するが、これらは本発明を限定するものでは
ない。
The present invention will be described in detail with reference to the following Examples and Comparative Examples, which do not limit the present invention.

【0010】実施例1 (1) CRP免疫比濁試薬 N−アッセイTIA CRP−S(ニットーボーメディ
カル株式会社)免疫比濁用試薬を使用した。試薬はトリ
ス緩衝液と抗血清液(20%抗CRPヤギ血清抗体)と
からなる。 (2) 直流パルス電圧印加装置 図1の実験装置を使用して、オシロスコープにより電極
間にかかる電位の条件を設定して直流パルス電圧を印加
した。(電極間3mm) (3) 測定方法 電極を張り合わせたガラスセルにトリス緩衝液840μ
lに検体36μlを分注し、37℃で5分間インキュベ
ーションを行い、吸光度(OD1)を測定した後、抗血
清液(20%抗CRPヤギ血清抗体)120μlを添加
し、直流パルス電圧(波高値6V、パルス幅10μ秒、
周波数10KHz)を30秒間印加した。更に5分間イ
ンキュベーションを行い、再度、吸光度(OD2)を測
定した。各種検体についてΔOD値(OD2−OD1)
を求め、検量線を作成した。検体としては、0.2%牛
血清アルブミンを含有するリン酸緩衝液(以下、0.2
%BSA−PBSと略す)を用いて、市販のCRP標準
液を希釈してCRP濃度0〜4.1mg/dlの検体を
調整し、測定に使用した。 (4) 結果 表1および図2に示した。
Example 1 (1) CRP immunoturbidimetric reagent N-assay TIA CRP-S (Nitto Bo Medical) was used. Reagents consist of Tris buffer and antiserum (20% anti-CRP goat serum antibody). (2) DC pulse voltage applying device Using the experimental device of FIG. 1, a DC pulse voltage was applied by setting the condition of the potential applied between the electrodes using an oscilloscope. (3 mm between electrodes) (3) Measurement method A Tris buffer 840 μm was placed in a glass cell with electrodes attached.
36 μl of the sample was dispensed to each sample, incubated at 37 ° C. for 5 minutes, and the absorbance (OD1) was measured. 6 V, pulse width 10 μs,
(Frequency 10 KHz) was applied for 30 seconds. Incubation was further performed for 5 minutes, and the absorbance (OD2) was measured again. ΔOD value (OD2-OD1) for various samples
And a calibration curve was prepared. The specimen was a phosphate buffer containing 0.2% bovine serum albumin (hereinafter referred to as 0.2% bovine serum albumin).
% BSA-PBS), a commercially available CRP standard solution was diluted to prepare a sample having a CRP concentration of 0 to 4.1 mg / dl, and used for measurement. (4) Results The results are shown in Table 1 and FIG.

【0011】[0011]

【表1】 [Table 1]

【0012】実施例2 実施例1で用いたと同じ各検体と試薬を使用して、反応
系に印加するパルス電圧を波高値4.6V、パルス幅2
0μ秒、周波数10KHzに設定し、18秒間印加した
他は、実施例1と同様に操作して、濁度変化を測定し検
量線を作成した。結果を表2および図3に示した。
Example 2 Using the same samples and reagents as used in Example 1, the pulse voltage applied to the reaction system was set to a peak value of 4.6 V and a pulse width of 2
The operation was performed in the same manner as in Example 1 except that the frequency was set to 0 μs, the frequency was set to 10 KHz, and the voltage was applied for 18 seconds, and the turbidity change was measured to prepare a calibration curve. The results are shown in Table 2 and FIG.

【0013】[0013]

【表2】 [Table 2]

【0014】比較例1 実施例1で用いたと同じ各検体と試薬を使用した。反応
系にパルス電圧の印加を行わない他は、実施例1と同様
に操作して、濁度変化を測定し検量線を作成した。結果
を図2および図3に示した。図2および図3に示した結
果から、本発明方法は、従来法に比べ免疫学的凝集反応
を促進させ、高感度に免疫学的反応性物質を検出又は測
定することが可能であることを示している。
Comparative Example 1 The same samples and reagents as used in Example 1 were used. Except that no pulse voltage was applied to the reaction system, the operation was performed in the same manner as in Example 1, and the turbidity change was measured to prepare a calibration curve. The results are shown in FIG. 2 and FIG. From the results shown in FIGS. 2 and 3, it can be seen that the method of the present invention promotes an immunological agglutination reaction and can detect or measure an immunologically reactive substance with high sensitivity compared to the conventional method. Is shown.

【0015】実施例3 電気分解を誘発する電圧の測定 塩化ナトリウムを精製水に溶解し、塩化ナトリウム濃度
0〜600mMに調整した。各濃度の塩化ナトリウム水
溶液の電気伝導度と電気分解開始電圧を測定した。印加
電圧は、直流パルス電圧(パルス幅10μ秒、周波数1
0KHz)を用いた。結果を表3および図4並びに表4
および図5に示した。
Example 3 Measurement of Voltage Inducing Electrolysis Sodium chloride was dissolved in purified water and adjusted to a sodium chloride concentration of 0 to 600 mM. The electrical conductivity and the electrolysis onset voltage of the sodium chloride aqueous solution of each concentration were measured. The applied voltage is a DC pulse voltage (pulse width 10 μsec, frequency 1
0 KHz). The results are shown in Table 3, FIG. 4, and Table 4.
And FIG.

【0016】[0016]

【表3】 [Table 3]

【0017】[0017]

【表4】 [Table 4]

【0018】図4から、電気伝導度と塩濃度は比例関係
にあり、また、図5から、電気分解を誘発する電圧は、
電気伝導度と対数関数の関係にあり、試薬の電気伝導度
が小さいほど電気分解を起こし難いことが分かる。
From FIG. 4, the electric conductivity and the salt concentration are in a proportional relationship, and from FIG. 5, the voltage that induces electrolysis is:
There is a logarithmic function relationship with the electric conductivity, and it can be seen that the lower the electric conductivity of the reagent, the more difficult it is to cause electrolysis.

【0019】[0019]

【発明の効果】本発明によれば、従来から用いられてい
る免疫比濁法若しくは免疫比朧法の試薬を使用して、従
来の方法よりも免疫学的凝集反応を促進させ、迅速に、
更に高感度で免疫学的反応性物質を検出又は測定するこ
とができる。
According to the present invention, immunological nephelometry or immunoturbidimetric reagents are used to promote immunological agglutination more rapidly than conventional methods,
Further, the immunologically reactive substance can be detected or measured with high sensitivity.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明で使用した直流パルス電圧印加実験装置
の概略図である。
FIG. 1 is a schematic diagram of a DC pulse voltage application experimental device used in the present invention.

【図2】従来法と本発明による方法の低濃度域の検量線
を比較したグラフである。
FIG. 2 is a graph comparing calibration curves in a low concentration range between a conventional method and a method according to the present invention.

【図3】従来法と本発明による方法の低濃度域の検量線
を比較したグラフである。
FIG. 3 is a graph comparing a calibration curve in a low concentration range between the conventional method and the method according to the present invention.

【図4】塩濃度と電気伝導度との関係を表すグラフであ
る。
FIG. 4 is a graph showing the relationship between salt concentration and electric conductivity.

【図5】電気伝導度と電気分解の誘発電圧との関係を表
すグラフである。
FIG. 5 is a graph showing a relationship between electric conductivity and induced voltage of electrolysis.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 吉村 佳典 茨城県つくば市千現1−13−7 イーグル 1 201号 (72)発明者 軽部 征夫 神奈川県川崎市宮前区東有馬1−3−16 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Yoshinori Yoshimura 1-1-13-7 Sengen, Tsukuba, Ibaraki Prefecture Eagle 1201 (72) Inventor Masao Karube 1-3-16 Higashiarima, Miyamae-ku, Kawasaki-shi, Kanagawa

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 抗原若しくは抗体を試薬として用いて、
免疫学的凝集反応により、免疫学的反応性物質を検出又
は測定する方法であって、該反応系に微小電圧を印加す
ることを特徴とする方法。
(1) using an antigen or an antibody as a reagent,
A method for detecting or measuring an immunologically reactive substance by an immunological agglutination reaction, wherein a minute voltage is applied to the reaction system.
【請求項2】 微小電圧が直流、直流パルス、若しくは
交流に由来する請求項1の方法。
2. The method of claim 1, wherein the minute voltage is derived from direct current, direct current pulses, or alternating current.
【請求項3】 微小電圧は反応系が電気分解を実質的に
起こさない電圧である請求項1の方法。
3. The method according to claim 1, wherein the minute voltage is a voltage at which the reaction system does not substantially cause electrolysis.
JP23182696A 1996-09-02 1996-09-02 Method for detecting or measuring immunological active substance Withdrawn JPH1073596A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23182696A JPH1073596A (en) 1996-09-02 1996-09-02 Method for detecting or measuring immunological active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23182696A JPH1073596A (en) 1996-09-02 1996-09-02 Method for detecting or measuring immunological active substance

Publications (1)

Publication Number Publication Date
JPH1073596A true JPH1073596A (en) 1998-03-17

Family

ID=16929632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23182696A Withdrawn JPH1073596A (en) 1996-09-02 1996-09-02 Method for detecting or measuring immunological active substance

Country Status (1)

Country Link
JP (1) JPH1073596A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005088309A1 (en) * 2004-03-12 2005-09-22 Pulse-Immunotech Corporation Method of measuring affinity substance
WO2009031274A1 (en) * 2007-09-03 2009-03-12 Panasonic Corporation Measuring chip
JP2017104870A (en) * 2017-03-24 2017-06-15 菊地 奈美枝 Method for producing strongly acidic water and strongly alkaline water

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005088309A1 (en) * 2004-03-12 2005-09-22 Pulse-Immunotech Corporation Method of measuring affinity substance
WO2009031274A1 (en) * 2007-09-03 2009-03-12 Panasonic Corporation Measuring chip
JP2017104870A (en) * 2017-03-24 2017-06-15 菊地 奈美枝 Method for producing strongly acidic water and strongly alkaline water

Similar Documents

Publication Publication Date Title
DK153589B (en) LATEX REAGENT FOR THE DETECTION AND DETERMINATION OF ANTIBODIES OR ANTIGANTS, A DIAGNOSTIC AGENT CONTAINING THE REAGENT, A PROCEDURE FOR PREPARING THIS REAGENT OR PROCEDURE FOR DETERMINING OR ORDERING
US8163151B2 (en) Assays for detection of Von Willebrand factor (vWF) multimers and for degradation of vWF by agents such as Adamts13 and related methods
EP1930726A1 (en) Method of assaying substance with affinity in sample including step of destroying blood-cell ingredient
CA2364288A1 (en) Enzyme-linked immuno-magnetic electrochemical biosensor
Tseng et al. Immunoaffinity capillary electrophoresis: Determination of binding constant and stoichiometry for antibody‐antigen interaction
US5055415A (en) Method for immunoassay procedure for the detection of antigen by reacting with antibody which increases its electrical charge and electrophoretic mobility
JP3300493B2 (en) Method for detecting or measuring the presence of a biologically specific reactive substance
JPH1073596A (en) Method for detecting or measuring immunological active substance
US20070000311A1 (en) Method for measuring substance having affinity
EP1930725A1 (en) Method of assaying substance with affinity in sample containing blood-cell ingredient
JPH026023B2 (en)
EP1724583A1 (en) Method of measuring affinity substance
JP3618797B2 (en) Immunoassay
JPH1073595A (en) Method for detecting or measuring presence of immunological active substance and reagent used for method thereof
WO1994009185A1 (en) Electrophoretic quantitation of specific binding complexes
JPH1073597A (en) Method for detecting or measuring immunological active substance
JPH03103765A (en) Immunoassay with fluorescent polarization by using immobilized antibody or antigen
Leek et al. Particle counting immunoassay (PACIA) V-its application to the determination of human placental lactogen
JPH09101307A (en) Method for detecting or measuring immunologically reactive substance
JP4288672B2 (en) Method for measuring affinity substances by particle aggregation and dilution
GB1600069A (en) Method for the measurement of antigens and antibodies
JPS6262291B2 (en)
JPH0949839A (en) Immunological measurement method
RU2102760C1 (en) Method and device for detecting biologically active substances in liquids
JP3461355B2 (en) Immunoelectrophoresis method

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20031104